Recently, sarcopenia has garnered renewed interest. Sarcopenia is a disease characterized
by decreased skeletal muscle mass and strength/function, which can impair the quality of life …

To date, sarcopenia is considered a patient-specific imaging biomarker able to predict
clinical outcomes. Several imaging modalities, including dual-energy X-ray absorptiometry …

Sarcopenia indicates a loss of skeletal muscle mass, a condition that leads to a decline in
physical performance. In 2018, the European Working Group on Sarcopenia in Older People …

OBJECTIVE. The purpose of this article is to review the nomenclature, clinical impact, and
diagnostic techniques characterizing sarcopenia. CONCLUSION. Sarcopenia—defined as …

Sarcopenia is defined as the loss of muscle mass or function and has been associated with
increased morbidity and mortality in a variety of diseased populations. Sarcopenia results …

As populations continue to age worldwide, the impact of sarcopenia on public health will
continue to grow. The clinically relevant and increasingly common diagnosis of sarcopenia …

Sarcopenia is a progressive, generalized skeletal muscle disorder characterized by
reduction of muscle mass and strength. It is associated with increased adverse outcomes …

Background Sarcopenia is defined as the loss of skeletal muscle mass and function
associated with aging. Muscle mass can be reliably and accurately quantified using clinical …

Sarcopenia is an age-related process of skeletal muscle loss associated with declining
physical performance, highly prevalent among older subjects, with a negative prognostic …

Sarcopenia is currently considered a geriatric syndrome increasing in older people. The
consequences of sarcopenia–in terms of impaired mobility, limited self-sufficiency and …